Cell Based Assays Congress 2014 Europe
Organization: Paradigm Global Events
|Event Date/Time: Feb 27, 2014||End Date/Time: Feb 28, 2014|
Cell-Based Assays 2014 Europe explores the latest thinking and techniques in this growing topic. Cell-based assays are becoming more important as companies realize their usage can significantly reduce the amount of clinical candidates failing to progress through the pipeline, as the assays demonstrably prove leads have a clinical effect. This event covers many topics, which are of vital scientific importance, such as ion channel assays, 3D assays, GPCR, as well as stem cell assays. Moreover, the event also looks at non-scientific areas of concern, such as post-analytics, quality control, and outsourcing, making this event a more rounded conference than other events on the same topic. As R&D budgets are squeezed and costs have to be accounted for, researchers have to be aware of other considerations in their assays, and this conference looks at these as well.
Book now and join us for an exciting two days of interactive and innovative discussions about the potentials of CBA and what are currently on offer and demands in the market today. This is a great opportunity to network with professionals in the field and enjoy learning about new developments in technologies, techniques, methods and detection involved in the CBA process.
Who Should ATTEND? Presidents, Chief Executives, Chief Scientific Officers, Chief Operating Officers, Vice Presidents, Senior Vice Presidents, Heads, Senior Directors, Directors, Clinicians, Principal Scientists, Principal Investigators, Managers, Project /Team Leaders in: • High-Throughput / High – Content Screening Operations • GPCR / Kinases / Molecular Pharmacology • Stem Cell Technologies & Platforms • Bioanalytical Development • Toxicology and Safety Testing • Pharmacovigilance and Safety Testing • In Vitro Sciences • Drug Delivery • Drug Discovery / Validation • Drug Development • Antibody Discovery • ADMET • Pre-clinical Development • Medical Chemistry • Compound Profiling • Cellular Imaging • Lead Generation • Pharmacodynamics • Pharmacokinetics • External/Contract Research • Medical Chemistry • Chemistry and Bioapplications • Global Research and Development • Business Development • Investment and Venture Capital • Neuroscience – Preclinical & Biomarkers • Neurodegenerative and Neurological Diseases
For more information contact: firstname.lastname@example.org